Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey

A survey of first-line antibiotic prescription in community-acquired lower respiratory tract infection (LRTI) by general practitioners (GP) was carried out simultaneously, using the same methodology in France, Germany, Italy, Spain and the UK. Data were obtained from 2,056 patients and 605 GPs. There was no antibiotic prescription in 17% of all LRTIs and 13% of community-acquired pneumonia (CAP) in the five countries taken together; and in 32% of all LRTIs and in 23% of CAP in Germany. Of patients with acute bronchitis, exacerbation of chronic bronchitis and viral lower respiratory tract infection, 87, 92 and 71% received antibiotics, respectively. The most frequent prescriptions were penicillins in France and the UK, third-generation cephalosporin in Italy, tetracycline in Germany and macrolide in Spain. The daily dosage of aminopenicillin prescribed was: 41% <1.5 g; 49% > or = 1.5 g and <3 g; and 10% > or = 3 g. In Italy, 53% of all antibiotics were injected in all LRTIs, and 71% in CAP; in contrast, antibiotic injection was lower than 2% both in the UK and Germany, with an average of 14% in the five countries combined. We conclude that there are variations in antibiotic prescription by GPs in Western Europe; differences are likely to be multifactorial, but could, in part, be explained by differences in health systems and sources of information available to GPs.

This article has been cited by other articles:

				M. Briel, P. Schuetz, B. Mueller, J. Young, U. Schild, C. Nusbaumer, P. Periat, H. C. Bucher, and M. Christ-Crain Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care Arch Intern Med, October 13, 2008; 168(18): 2000 - 2007. [Abstract] [Full Text] [PDF]

				R. M Hopstaken, C. C Butler, J. W M Muris, J A. Knottnerus, A. D M Kester, P. E L M Rinkens, and G.-J. Dinant Do clinical findings in lower respiratory tract infection help general practitioners prescribe antibiotics appropriately? An observational cohort study in general practice Fam. Pract., April 1, 2006; 23(2): 180 - 187. [Abstract] [Full Text] [PDF]

				P. Little, K. Rumsby, J. Kelly, L. Watson, M. Moore, G. Warner, T. Fahey, and I. Williamson Information Leaflet and Antibiotic Prescribing Strategies for Acute Lower Respiratory Tract Infection: A Randomized Controlled Trial JAMA, June 22, 2005; 293(24): 3029 - 3035. [Abstract] [Full Text] [PDF]

				R. Wahlstrom, E. Hummers-Pradier, C. S. Lundborg, M. Muskova, P. Lagerlov, P. Denig, T. Oke, and D M. C. de Saintonge Variations in asthma treatment in five European countries--judgement analysis of case simulations Fam. Pract., October 1, 2002; 19(5): 452 - 460. [Abstract] [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				A. Ortqvist Treatment of community-acquired lower respiratory tract infections in adults Eur. Respir. J., July 1, 2002; 20(36_suppl): 40S - 53s. [Abstract] [Full Text] [PDF]

				C. Raherison, P. Peray, R. Poirier, P. Romand, J-P. Grignet, P. Arsac, A. Taytard, and J-P. Daures Management of lower respiratory tract infections by French general practitioners: the AIR II study Eur. Respir. J., February 1, 2002; 19(2): 314 - 319. [Abstract] [Full Text] [PDF]

				C. C. Butler, P. Kinnersley, H. Prout, S. Rollnick, A. Edwards, and G. Elwyn Antibiotics and shared decision-making in primary care J. Antimicrob. Chemother., September 1, 2001; 48(3): 435 - 440. [Abstract] [Full Text] [PDF]

				M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Eur. Respir. J., May 1, 2001; 17(5): 928 - 933. [Abstract] [Full Text] [PDF]

				R. Wilson Bacteria, antibiotics and COPD Eur. Respir. J., May 1, 2001; 17(5): 995 - 1007. [Abstract] [Full Text] [PDF]

				S. Esposito Outpatient parenteral treatment of bacterial infections: the Italian model as an international trend? J. Antimicrob. Chemother., June 1, 2000; 45(6): 724 - 727. [Full Text] [PDF]

				J. Macfarlane, W F Holmes, and R. Macfarlane Issues at the interface between primary and secondary care in the management of common respiratory disease bullet 6: Do hospital physicians have a role in reducing antibiotic prescribing in the community? Thorax, February 1, 2000; 55(2): 153 - 158. [Full Text]

				W. F Holmes and M. Woodhead Issues at the interface between primary and secondary care in the management of common respiratory disease bullet 4: Providing better care for patients who may have pneumonia Thorax, October 1, 1999; 54(10): 925 - 928. [Full Text]

				M. Miravitlles, C. Espinosa, E. Fernandez-Laso, J. A. Martos, J. A. Maldonado, and M. Gallego Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD Chest, July 1, 1999; 116(1): 40 - 46. [Abstract] [Full Text] [PDF]